From October 1, 2023 to November 13, 2023, the company has repurchased 177,900 shares, representing 0.55% for CAD 0.58 million. With this, the company has completed the repurchase of 397,269 shares, representing 1.23% for CAD 1.55 million under the buyback announced on November 10, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.35 CAD | +0.75% | -2.47% | -15.19% |
07/06 | Transcript : HLS Therapeutics Inc. - Shareholder/Analyst Call | |
28/05 | HLS Therapeutics Notes Role of Pharmaceutical Support Programs on Persistence with Clozapine Treatment in Quebec Study | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.19% | 77.82M | |
-2.46% | 23.95B | |
+14.23% | 8.7B | |
+1.47% | 8.29B | |
-32.92% | 6.7B | |
+18.62% | 5.38B | |
+1.10% | 4.08B | |
-9.24% | 3.79B | |
-10.20% | 3.3B | |
+7.11% | 3.19B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- Tranche Update on HLS Therapeutics Inc.'s Equity Buyback Plan announced on November 10, 2022.